1,8-Diazabicyclo(5.4.0)undec-7-ene
Especificaciones
6674-22-2Número CAS
229-713-7Número CE
2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepineNombre IUPAC
C9H16N2Fórmula química
152.24 g/molPeso molecular
6674-22-2; 1,8-Diazabicyclo[5.4.0]undec-7-ene; 1,8-Diazabicyclo(5.4.0)undec-7-ene; Pyrimido[1,2-a]azepine, 2,3,4,6,7,8,9,10-octahydro-; DTXSID2049424; H1ILJ6IBUX; AMICURE DBUE; DABCO DBU; NSC-111184; DTXCID1029384; ALCANPOUDRE DBU 70-3KG; NSC-230466; 1,8-DIAZA-7-BICYCLO(5.4.0)UNDECENE; Pyrimido(1,2-a)azepine, 2,3,4,6,7,8,9,10-octahydro-; 1,8-diazabicyclo(5.4.0]undec-7-ene; 1,8-Diazabicyclo[5.4.0}undec-7-ene; 1,8-diazabicyclo{5.4.0]undec-7-ene; RefChem:73734; 1,8-DBU; 229-713-7; 2,3,4,6,7,8,9,10-Octahydropyrimido[1,2-a]azepine; DBU; 1,8-Diazabicyclo[5.4.0]-7-undecene; 1,8-diazabicyclo[5,4,0]undec-7-ene; 2H,3H,4H,6H,7H,8H,9H,10H-pyrimido[1,2-a]azepine; MFCD00006930; 1,8-diazabicyclo(5,4,0)undec-7-ene; 1,8-diazabicyclo[5,4,0]-undec-7-ene; CHEMBL1489129; 1,8-diazabicyclo[5.4.0]undec-7-en; 1,5-Diazabicyclo[5.4.0]-5-undecene; 1,5-Diazabicyclo[5.4.0]undec-5-ene; 2,3,4,6,7,8,9,10-Octahydropyrimidol[1,2-a]azepine; 1,5-Diazabicyclo(5.4.0)undec-5-ene; 1,8-diazabicyclo[5.4.0]undeca-7-ene; 1,8-diazabicyclo (5.4.0)undec-7-ene; 1,8-diazabicyclo [5.4.0]-7-undecene; UNII-H1ILJ6IBUX; 1,8-diazabicyclo(5.4.0)undec-7ene; 1,8-diazabicyclo[5.4.0]undec-7ene; 1,8-diazabicyclo(5.4.0)undec-7-en; 1,8-diazabicyclo[5.4.0)-7-undecene; 1,8-diazabicyclo(5.4.0)undeca-7-ene; 1,8-diazabicyclo [5.4.0]undec-7-ene; 1,8-diazabicyclo(5,4,0)-undec-7-ene; 1,8-diazabicyclo (5,4,0) undec-7-ene; 1,8-diazabicyclo (5.4.0) undec-7-ene; 1,8-diazabicyclo [5,4,0] undec-7-ene; 1,8-diazabicyclo [5.4.0] undec-7-ene; 1,8-diazabicyclo-[5,4,0]-undec-7-ene; 1,8-Diazabicyclo-(5,4,0)-undec-7-ene; 2,3,4,6,7,8,9,10-octahydropyrimido(1,2-a)azepine; 1,8-diazabicyclo[5,4,0]undec-7-en; MLS000039793; CCRIS 9417; 2,3,4,5-tetrahydro-6H,7H,8H,9H,10H-pyrimidino[1,2-a]azaperhydroepine; EINECS 229-713-7; Tipiracil Impurity 7; NSC 111184; NSC 230466; 1,8-Diazabicyclo[5.4,0]undec-7-ene; EC 229-713-7; SCHEMBL3047; orb1908964; orb2900208; SCHEMBL17417853; SCHEMBL19066792; 2,3,4,6,7,8,9,10-Octahydropyrimido(1,2-alpha)azepine; HMS2456O11; STR00657; 1,5-Diaza(5,4,0)undec-5-ene; 1,5-diaza(5.4.0)undec-5-ene; Tox21_202939; BDBM50000167; EBC-04306; NSC111184; SBB055512; TN7195; 1,8-Diazabicyclo[540]undec-7-ene; 1,8-diazabicyclo(5.4.0)undecene-7; 1,8-diazabicyclo[5.4.0]undec7-ene; 1,8-diazabicylo[5.4.0]undec-7-en; 1,8diazabicyclo[5.4.0]undec-7-ene; AKOS009031277; 1,8-diazabicylo[5.4.0]undec-7-ene; AC-2471; FD46281; PS-4098; 1,5-diazabicyclo[5,4,0]-5-undecene; 1,8 diazabicyclo[5.4.0]undec-7-ene; 1,8-diaza-bicyclo[5.4.0]undec-7ene; 1,8-diazabicyclo-[5.4.0]undec-7ene; 1,8-diazabicyclo[5,4,0]-7-undecene; 1,8-diazabicyclo[5,4,01-7-undecene; 1,8-diazabicyclo[5.4,0]-7-undecene; 1,8-diazabicyclo[5.4.0]-undec-7ene; 1,8-diazabicyclo[5.4.0]undec 7-ene; 1,8-diazabicyclo[5.4.0]undeca-7-en; 1,8-diazabicylco[5,4,0]undec-7-ene; 1,8-diazabicylco[5.4.0]undec-7-ene; 1.8-diazabicyclo[5,4,0]-7-undecene; 1.8-diazabicyclo[5,4,0]undec-7-ene; 1.8-diazabicyclo[5.4.0]-7-undecene; 1.8-diazabicyclo[5.4.0]undec-7-ene; 1,8-diazabicyclo[5,4,0]undeca-7-ene; 1,8-diazabicylo[5.4.0] undec-7-ene; l,8-diazabicyclo[5.4.0] undec-7-ene; NCGC00260485-01; 1, 8-Diazabicyclo[5.4.0]undec-7-ene; 1,8 -diazabicyclo[5,4,0]undec-7-ene; 1,8 diazabicyclo [5.4.0] undec-7ene; 1,8 Diazabicyclo[5,4,0]-undec-7-ene; 1,8- diazabicyclo[5.4.0]undec-7-ene; 1,8-diaza bicyclo[5,4,0]undec-7-ene; 1,8-diaza-bicyclo[5.4.0]undec-7-ene; 1,8-diazabicyclo [5,4,0]-7-undecene; 1,8-diazabicyclo [5,4,0]undec-7-ene; 1,8-Diazabicyclo-[5,4,0]undec-7-ene; 1,8-diazabicyclo-[5.4.0]undec-7-ene; 1,8-diazabicyclo[5, 4.0]undec-7-ene; 1,8-Diazabicyclo[5,4,0] undec-7-ene; 1,8-diazabicyclo[5.4.0] undec-7-ene; 1,8-diazabicyclo[5.4.0]-undec-7-ene; 1,8-diazabicyclo[5.4.0]-undeca-7-ene; 1,8-diazabicyclo[5.4.0]undecan-7-ene; 1.8-diazabicyclo [5.4.0]undec-7-ene; 1.8-diazabicyclo[5.4.0]-undec-7-ene; BP-25116; BP-30004; SMR000036948; 1,8-diaza-bicyclo[5.4.0]-undec-7-ene; 1,8-diazabicyclo [5.4.0]-undec-7-ene; 1,8-diazabicyclo-[ 5.4.0]undec-7-ene; 1,8-diazabicyclo-[5.4.0]-undec-7-ene; 1,8-diazabicyclo[5.4.0]- undec-7-ene; 1.8-diazabicyclo (5.4.0) undec-7-ene; CAS-6674-22-2; 1, 8-Diazabicyclo [5.4.0]undec-7-ene; DB-291150; 1,8-diazabicyclo- [5.4.0]-undec-7-ene; CS-0009461; D1270; NS00004166; ST50308548; 1,8-Diazabicyclo[5.4.0]undec-7-ene(DBU); EN300-21428; 1,8-Diazabicyclo[5.4.0]undec-7-ene, 98%; D72474; F033415; Pyrimido[1, 2,3,4,6,7,8,9,10-octahydro-; Q306166; 1,8-DIAZABICYCLO(5.4.0)UNDEC-7-ENE [MI]; 2,3,4,6,7,8,9,10-octahydro-pyrimido[1,2-a]azepin; 2,3,4,6,7,8,9,10-Octahydro-pyrimido[1,2-a]azepine; 2,3,4,6,7,8,9,10-octahydropyrimido-[1,2-a]azepine; F0001-1771; Z104496570; 2,3,4,6,7,8,9,10-octahydro -pyrimido[1,2-a]azepin; 2,4,6,7,8,9,10-Octahydropyrimido[1,2-.alpha.]azepine; 1,8-Diazabicyclo[5.4.0]undec-7-ene, purum, >=98.0% (GC); 2,3,4,6,7,8,9,10-Octahydropyrimido(1,2-.alpha.)azepine; 1,8-Diazabicyclo[5.4.0]undec-7-ene, puriss., >=99.0% (GC)Sinónimos
